Hirsutism future or investigational therapies

Jump to: navigation, search

Hirsutism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hirsutism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasonography

Treatment

Medical Therapy

Pharmacological therapy
Non-pharmacological therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hirsutism future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hirsutism future or investigational therapies

CDC on Hirsutism future or investigational therapies

Hirsutism future or investigational therapies in the news

Blogs on Hirsutism future or investigational therapies

Directions to Hospitals Treating Hirsutism future or investigational therapies

Risk calculators and risk factors for Hirsutism future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: ; Rasam Hajiannasab M.D.[2]

Overview

Fluridil is one of the new topical treatment options for hirsutism which is not available yet.

Future or Investigational Therapies

Fluridil (2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl]-3-(2,2,2-trifluoroacetylamino)ropanamide) is a new topical antiandrogen agent and has been developed for hyperandrogenic skin syndromes.

A clinical study has shown that a 2% fluridil gel is a safe and effective treatment method of hirsutism and also has no effect on libido or sexual function but Fluridil is not available yet.[1]

References

  1. Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M (2002). "Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience". Dermatol Surg. 28 (8): 678–85. PMID 12174057.